Our results are in line with recent data on breast cancer, providing evidences for a role of estrogens in promoting ER-negative tumor formation by influencing the mobilization and recruitment of a pro-angiogenic population of bone marrow-derived cells; a functional ERα in the BMDCs has been deemed necessary for this effect [33, 54]. The gene discussed is ESR1; the disease is breast cancer.